GRIECO, PAOLO
 Distribuzione geografica
Continente #
AS - Asia 9.883
NA - Nord America 8.079
EU - Europa 7.048
SA - Sud America 1.222
AF - Africa 231
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 11
Totale 26.486
Nazione #
US - Stati Uniti d'America 7.743
SG - Singapore 4.387
RU - Federazione Russa 3.126
CN - Cina 1.940
VN - Vietnam 1.805
IT - Italia 1.191
BR - Brasile 984
HK - Hong Kong 805
DE - Germania 439
FR - Francia 391
FI - Finlandia 343
UA - Ucraina 318
IE - Irlanda 277
NL - Olanda 273
GB - Regno Unito 227
SE - Svezia 220
CA - Canada 199
JP - Giappone 167
IN - India 154
AR - Argentina 89
MX - Messico 81
BD - Bangladesh 75
KR - Corea 69
ZA - Sudafrica 65
PL - Polonia 59
IQ - Iraq 56
TH - Thailandia 56
TR - Turchia 55
ES - Italia 52
CI - Costa d'Avorio 51
PH - Filippine 48
PK - Pakistan 42
ID - Indonesia 39
EC - Ecuador 37
TW - Taiwan 31
BE - Belgio 25
PY - Paraguay 24
CO - Colombia 23
MA - Marocco 23
IR - Iran 22
SA - Arabia Saudita 22
AT - Austria 19
VE - Venezuela 19
CL - Cile 17
BG - Bulgaria 14
EG - Egitto 14
LT - Lituania 14
UY - Uruguay 13
AE - Emirati Arabi Uniti 12
UZ - Uzbekistan 12
DZ - Algeria 11
PE - Perù 11
IL - Israele 10
TN - Tunisia 10
CZ - Repubblica Ceca 9
EU - Europa 9
KE - Kenya 9
ET - Etiopia 8
HN - Honduras 8
JM - Giamaica 8
AU - Australia 7
AZ - Azerbaigian 7
JO - Giordania 7
KZ - Kazakistan 7
LB - Libano 7
NP - Nepal 7
PA - Panama 7
PS - Palestinian Territory 7
TT - Trinidad e Tobago 7
CH - Svizzera 6
MY - Malesia 6
NG - Nigeria 6
SN - Senegal 6
BY - Bielorussia 5
GR - Grecia 5
GT - Guatemala 5
MK - Macedonia 5
NZ - Nuova Zelanda 5
PT - Portogallo 5
AF - Afghanistan, Repubblica islamica di 4
AL - Albania 4
BO - Bolivia 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
KG - Kirghizistan 4
BA - Bosnia-Erzegovina 3
BB - Barbados 3
HU - Ungheria 3
KH - Cambogia 3
LV - Lettonia 3
LY - Libia 3
OM - Oman 3
RO - Romania 3
SV - El Salvador 3
TJ - Tagikistan 3
AM - Armenia 2
AO - Angola 2
BH - Bahrain 2
BS - Bahamas 2
BW - Botswana 2
Totale 26.441
Città #
Singapore 1.957
San Jose 1.190
Hong Kong 770
Moscow 755
Chandler 720
Beijing 570
Ashburn 569
Ho Chi Minh City 543
Hanoi 398
Naples 370
Santa Clara 337
Jacksonville 313
Hefei 297
The Dalles 267
Amsterdam 249
Lauterbourg 236
Princeton 220
Los Angeles 217
Millbury 215
Dallas 191
Boston 164
Nanjing 163
Napoli 147
Tokyo 137
Buffalo 128
New York 117
São Paulo 116
Munich 103
Wilmington 99
Ottawa 97
Des Moines 79
Dong Ket 78
Redondo Beach 76
Houston 73
Woodbridge 70
Haiphong 68
Da Nang 66
Turku 55
Ann Arbor 53
Frankfurt am Main 52
Orem 52
Warsaw 52
Helsinki 50
Seattle 49
Nanchang 47
Seoul 45
Brooklyn 42
Chicago 42
Shenyang 41
Denver 39
Mexico City 37
Rome 37
Biên Hòa 35
Norwalk 35
Bangkok 33
Rio de Janeiro 33
Stockholm 33
Falkenstein 32
Nuremberg 32
London 31
Poplar 31
Dublin 30
Montreal 30
Hebei 29
Jiaxing 29
Atlanta 28
Chennai 28
Tianjin 28
Changsha 27
Johannesburg 27
Kronberg 27
Milan 27
Toronto 27
Lappeenranta 25
Lawrence 25
North Bergen 24
Boardman 23
Council Bluffs 23
Hải Dương 23
Phoenix 23
Can Tho 21
Baghdad 20
Lahore 20
Manchester 20
Mumbai 20
Dearborn 19
Düsseldorf 19
Brasília 16
Columbus 16
Hangzhou 16
San Francisco 16
Belo Horizonte 15
Charlotte 15
Shanghai 15
Buenos Aires 14
Falls Church 14
Guayaquil 14
Porto Alegre 14
Brussels 13
Caserta 13
Totale 13.986
Nome #
" Molecular Modelingof the Urotensin-II receptor Complex" 240
Functional Selectivity Revealed by N-Methylation Scanning of Human Urotensin II and Related Peptides 233
Urokinase receptor derived peptides as potent inhibitors of the formyl peptide receptor type 1-triggered cell migration 198
Screening Platform toward New Anti-HIV Aptamers Set on Molecular Docking and Fluorescence Quenching Techniques 188
Antimicrobial peptide Temporin-L complexed with anionic cyclodextrins results in a potent and safe agent against sessile bacteria 180
Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs 179
Alanine scanning analysis and structure-function relationships of the frog-skin antimicrobial peptide temporin-1Ta 172
Microwave-Assisted Synthesis of 2-Methyl-1H-indole-3-carboxylate Derivatives via Pd-Catalyzed Heterocyclization 171
Cyclization of the urokinase receptor-derived Ser-Arg-Ser-Arg-Tyr peptide generates a potent inhibitor of trans-endothelial migration of monocytes 168
Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer 164
Discovery of Novel Potent and Selective Agonists at the Melanocortin-3 Receptor 163
The Outcomes of Decorated Prolines in the Discovery of Antimicrobial Peptides from Temporin-L 159
Unraveling the active conformation of urotensin II 154
Novel Antimicrobial Peptide from Temporin L in The Treatment of Staphylococcus pseudintermedius and Malassezia pachydermatis in Polymicrobial Inter-Kingdom Infection 154
Unveiling the mechanism of action of acylated temporin L analogues against multidrug-resistant Candida albicans 153
Discovery of New Potent Ligands at Human Urotensin-II Receptor 153
An investigation into the origin of the biased agonism associated with the urotensin II receptor activation 153
Antifungal and Antibiofilm Activity of Cyclic Temporin L Peptide Analogues against Albicans and Non-Albicans Candida Species 149
"3D Structural analysis of Urotensin-II analogues in membrane mimetic environment" 148
The urokinase receptor-derived cyclic peptide [SRSRY] suppresses neovascularization and intravasation of osteosarcoma and chondrosarcoma cells 148
Glycine-replaced derivatives of [Pro3,DLeu9]TL, a temporin L analogue: Evaluation of antimicrobial, cytotoxic and hemolytic activities 146
Synthesis and Pharmacological Evaluation of a Novel Peptide Based on Anemonia sulcata BDS-I Toxin as a New KV3.4 Inhibitor Exerting a Neuroprotective Effect Against Amyloid-β Peptide 143
Unlocking the potential of protein-derived peptides to target G-quadruplex DNA: from recognition to anticancer activity 142
Short PlGF-derived peptides bind VEGFR-1 and VEGFR-2 in vitro and on the surface of endothelial cells 142
Urotensin II(4-11) Azasulfuryl Peptides: Synthesis and Biological Activity 141
Improved synthesis on solid phase of dithiocarbamic cRGD-derivative and 99m Tc-radiolabelling 141
Temporin L-derived peptide as a regulator of the acute inflammatory response in zymosan-induced peritonitis 140
Urotensin-II-Targeted Liposomes as a New Drug Delivery System towards Prostate and Colon Cancer Cells 140
Synthesis and Binding Affinities for 5-HT1A, 5-HT2A and 5-HT2C receptors of a series of 1- and 2-(4-arylpiperazinylalkyl)-4-(benzoyl)-1,2,3-triazole derivatives. 137
Lead Optimization of P5U and Urantide: Discovery of Novel Potent Ligands at the Urotensin-II Receptor 137
Antimicrobial Activity of a Lipidated Temporin L Analogue against Carbapenemase-Producing Klebsiella pneumoniae Clinical Isolates 137
Synthetic Amphipathic β-Sheet Temporin-Derived Peptide with Dual Antibacterial and Anti-Inflammatory Activities 136
In vitro effects of protein fractions from Controne beans (Phaseolus vulgaris L. ecotype Controne) on intestinal permeability, ACE and α-amylase activities 136
Synthesis of novel lignan-like compounds and their antimicrobial activity 135
Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors 135
Synthesis, biological activity and conformational study of 1,4-benzoxazine dderivatives as potassium channel modulators. 134
Design, Synthesis, and Cytotoxic Evaluation of AcylDerivatives of 3-Aminonaphtho[2,3-b]thiophene-4,9-dione, a Quinone-Based System 134
Synthesis and antinociceptive Activity of Peptides Related to Interleukin-1b193-195 Lys-Pro-Thr. 133
D-Amino Acids Containing Temporin L Analogues 133
Investigation on side-product formation during the synthesis of a lactoferrin-derived lactam-bridged cyclic peptide 133
HOST DEFENSE TEMPORIN 1 PEPTIDES AND THEIR POTENTIAL AS ANTIVIRAL AGENTS 133
Synthesis and in vitro activities of NK-1 antagonists derived from L-Triptophan. 131
Novel approach to the synthesis of diaza-bridged heterocycle derivative. 131
The Anemonia sulcata Toxin BDS-I Protects Astrocytes Exposed to Aβ1–42 Oligomers by Restoring [Ca2+]i Transients and ER Ca2+ Signaling 131
Novel α-MSH peptide analogues with broad spectrum antimicrobial activity. 130
A new therapeutic approach to erectile dysfunction: Urotensin-II receptor high affinity agonist ligands 129
New biologic (Ab-IPL-IL-17) for IL-17-mediated diseases: identification of the bioactive sequence (nIL-17) for IL-17A/F function 128
Phenol derived CVFM analogs inhibitors of ras farnesyl transferase possessing cellular in vitro activity. 128
Breast tumor cell invasion and pro-invasive activity of cancer-associated fibroblasts co-targeted by novel urokinase-derived decapeptides 128
Selective melanocortin MC4 receptor agonists reverse haemorrhagic shock and prevent multiple organ damage 127
Structure-Activity Study of the Peptides P5U and Urantide by the Development of Analogues Containing Uncoded Amino Acids at Position9 127
Novel and Selective avb3 Receptor Peptide Antagonist: Design, Synthesis, and Biological Behavior 126
Design, synthesis, and conformational analysis of Melanotropin analogues of MTII and SHU9119. 125
Design, synthesis and efficacy of novel G protein-coupled receptor kinase 2 inhibitors 125
New insight into the binding mode of peptides at urotensin-II receptor by Trp-constrained analogues of P5U and urantide. 124
Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses 124
A structure – activity relationship study on position –2 of the Gas C-terminal peptide able to inhibit Gs activation by A2A adenosine receptor. 123
First-in-Class Cyclic Temporin L Analogue: Design, Synthesis, and Antimicrobial Assessment 123
Ad-hoc modifications of cyclic mimetics of SOCS1 protein: Structural and functional insights 122
Synthesis of novel indol-based ring systems by acid-catalyzed condensation from -amino aldehydes and L-Trp-OMe 122
Design, Synthesis, and Conformational Analysis of Melanotropin Analogues of MTII and SHU9119 122
NEW INSIGHT INTO THE BINDING MODE OF CYCLIC MELANOCORTIN LIGANDS AT THE MC4 RECEPTOR 122
Potential Functional Snacks: Date Fruit Bars Supplemented by Different Species of Lactobacillus spp 121
SAR study and conformational analysis of a series of novel peptide G protein-coupled receptor kinase 2 inhibitors 121
Treatment with a Urokinase Receptor-derived Cyclized Peptide Improves Experimental Colitis by Preventing Monocyte Recruitment and Macrophage Polarization 121
Urotensin II receptor expression in patients with ulcerative colitis: a pilot study 121
Discovery of a new class of triazole based inhibitors of acetyl transferase KAT2A 120
Formulazione liquida micronizzabile per il trattamento terapeutico dell'acne e di altre patologie cutanee correlate 120
Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion 120
Chemical modifications in the seed region of miRNAs 221/222 increase the silencing performances in gastrointestinal stromal tumor cells 120
Characterization of KRAS Mutational Regression in Oligometastatic Patients 119
Synthesis of new pyrido[4,3-g and 3,4-g]quinoline-5,10-dione and dihydro thieno[[2,3-g and 3,2-g]quinoline-4,9-dione derivatives and perliminary evaluation of cytotoxic activity 119
Synthesis, Biological Activity and Conformational Study of 1,4-Benzoxazine Derivatives as Potassium Channel Modulators 119
Glioblastoma Cell Migration, Invasion and Vasculogenic Mimicry Downmodulated by Novel uPAcyclin Derivatives 118
Biophysical and biochemical characterization of a liposarcoma-derived recombinant MnSOD protein acting as an anticancer agent 118
Rationally designed α-conotoxin analogues maintained analgesia activity and weakened side effects 118
Bicyclic β‐sheet mimetics that target the transcriptional coactivator β‑catenin and inhibit Wnt signaling 117
Binding site of loperamide: automated docking of loperamide in human mi - and delta -opioid receptors. 116
Urotensin II: A Novel Target in Human Corpus Cavernosum 116
Urantide Conformation and Interaction with the Urotensin-II Receptor 116
Structure-Activity Relationship, Conformational and Biological Studies of Temporin L Analogues 116
NMR analysis of synthetic peptides agonist to PTPRJ, a receptor-type protein tyrosine phosphatase with tumor suppressor activity 116
Peptide functionalization of silicon for detection and classification of prostatic cells 116
Synthesis and pharmacologi-cal activity of 2-(substituted)-3-{2-[(4-phenyl-4-cyano)piperidino]ethyl}-1,3-thiazolidin-4-ones. 115
Design, Synthesis, and Evaluation of Gluten Peptide Analogs as Selective 401 Inhibitors of Human TG2 115
DESIGN AND SYNTHESIS OF N-METHYL DERIVATIVES OF UROTENSIN-II 115
A novel quinone–based derivative (DTNQ-Pro) induces apoptotic death via modulation/reduction of hsp expression in a human colon adenocarcinoma cell line 114
Urotensin-II Ligands: An Overview from Peptide to Nonpeptide Structures 114
Boosting Fmoc Solid-Phase Peptide Synthesis by Ultrasonication 114
Activation of Melanocortin Receptors MC1 and MC5 Attenuates Retinal Damage in Experimental Diabetic Retinopathy 113
The IkB Kinase Inhibitor, NEMO-binding Domain Peptide, inhibits rat balloon injury-induced neointimal formation. 112
Chemical characterization of wheat-based waste derived from a pharmaceutical process for its potential valorization 111
Expanding Structure-Activity Relationships of Human Urotensin II Peptide Analogues: A Proposed Key Role of the N-Terminal Region for Novel Urotensin II Receptor Modulators 111
“Matters Arising” on a Recent Biologic (Ab-IPL-IL-17™) for IL-17-Mediated Diseases 111
Design and Synthesis of Spirotryprostatin-inspired Diketopiperazine Systemsfrom Prolyl Spirooxoindolethiazolidine Derivatives 111
SMALL PEPTIDES AS ANTAGONISTS OF PED-PEA15/PLD1 PROTEIN COMPLEX 111
Conformational study on cyclic melanocortin ligands and new insight into their binding mode at the MC4 receptor 111
Development of Cyclic Peptide Inhibitors of GRK2 111
Sar Study Of P5u And Urantide Analogues Modified At Position 9 111
Unveiling the interaction between DNA G-quadruplexes and RG-rich peptides 111
Totale 13.362
Categoria #
all - tutte 83.339
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.339


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021238 0 0 0 0 0 0 0 0 0 40 102 96
2021/20221.275 32 4 11 16 18 50 16 56 273 92 171 536
2022/20231.779 273 126 55 162 201 193 18 153 266 224 82 26
2023/20241.239 57 182 210 53 84 88 39 141 17 32 237 99
2024/20257.256 389 454 60 113 107 372 695 455 736 805 2.451 619
2025/202612.386 1.503 931 1.456 1.248 2.164 546 1.553 707 1.541 737 0 0
Totale 26.914